Skip to main content
OpenTrials
Completed

NCT Number: NCT02747381

The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients

This study evaluates the effect of vitamin D supplementation in the form of Alfacalcidol on the the pulmonary function of adult asthmatic Egyptian patients

Completed

Looking for future studies?

Notify Me

Key information

About this study

Asthmatic patients are recruited and divided into two groups. One receives Alfacalcidol beside their normal medications while the other acts as a control group receiving the normal asthma medication.

Both groups are followed up for four months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with asthma
  • Non-smokers

Exclusion criteria

  • Liver impairment
  • Kidney impairment
  • Patients receiving digoxin
  • Known hypersensitivity to 1α-hydroxyvitamin D3, vitamin D or any of its analogues and derivatives
  • Hypercalcaemia
  • Hyperphosphatemia
  • Pregnancy and breast-feeding
  • Patients on nutritional supplements with a potential effect on 25(OH)D serum concentrations
  • Had a History of stones in the urinary tract or diseases of calcium or bone metabolism

Treatment and study plan

Alfacalcidol

Dietary Supplement

1-alpha hydroxy cholecalciferol 1 mcg

Other names: One alpha

Primary outcomes

  1. forced expiratory volume % predicted values

    Time frame: 4 months

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Apr 21, 2016
Registry last updated
Apr 21, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.